[STATEMENT ON BLEEDING CONCERNS] A Comparative Overview of Prescription Omega-3 Fatty Acid Products

Source: http://www.brainhealtheducation.org/statement-on-bleeding-concerns-a-comparative-overview-of-prescription-omega-3-fatty-acid-products/

Drug Interactions The following products have been investigated in clinical drug–drug interaction studies with the RxOM3FAs [prescription omega-3 fatty acids]: warfarin (Vascepa, Epanova); omeprazole (Vascepa); rosiglitazone (Vascepa); atorvastatin (Lovaza, Vascepa, Omtryg); rosuvastatin (Lovaza, Omtryg); and simvastatin (Lovaza, Omtryg, Epanova).1–4,23–28 No drug–drug interactions were observed. The package inserts for all RxOM3FAs note that patients who are receiving

Read More…

…

Source: http://www.brainhealtheducation.org/statement-on-bleeding-concerns-a-comparative-overview-of-prescription-omega-3-fatty-acid-products/

Drug Interactions The following products have been investigated in clinical drug–drug interaction studies with the RxOM3FAs [prescription omega-3 fatty acids]: warfarin (Vascepa, Epanova); omeprazole (Vascepa); rosiglitazone (Vascepa); atorvastatin (Lovaza, Vascepa, Omtryg); rosuvastatin (Lovaza, Omtryg); and simvastatin (Lovaza, Omtryg, Epanova).1–4,23–28 No drug–drug interactions were observed. The package inserts for all RxOM3FAs note that patients who are receiving

Read More…

…

What Do You Think?

comments

Translate »